We assessed the contribution of NOD2 recessive inheritance in a broader, heterogeneous cohort of adult IBD patients, similar to those recruited for GWAS, and found that recessive inheritance of variants in NOD2 account for 6.5% of these IBD patients, including 9.9% of CD cases. The gene discussed is NOD2; the disease is inflammatory bowel disease.